Therapeutic response to reboxetine in patients with major depressive disorder

被引:0
|
作者
Dabrowska, E
Haller, T
Bartlett, C
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S206 / S207
页数:2
相关论文
共 50 条
  • [1] An open label clinical trial of reboxetine in patients with major depressive disorder
    Demir, B
    Soykan, A
    Devrimci-Ozguven, H
    Gögüs, A
    Haller, T
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S221 - S221
  • [2] Reboxetine in the treatment of elderly inpatients with Major Depressive Disorder
    Vasile, D
    Vasiliu, O
    Baloescu, A
    Grigorescu, G
    Gheorghe, MD
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S41 - S41
  • [3] The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder
    Caudill, Marissa M.
    Hunter, Aimee M.
    Cook, Ian A.
    Leuchter, Andrew F.
    CLINICAL EEG AND NEUROSCIENCE, 2015, 46 (04) : 277 - 284
  • [4] Switching to reboxetine: An efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine
    Fava, M
    McGrath, PJ
    Sheu, WP
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (04) : 365 - 369
  • [5] Comparison of reboxetine and sertraline in terms of efficacy and safety in major depressive disorder
    Eker, SS
    Akkaya, C
    Akgöz, S
    Sarandöl, A
    Kirli, S
    TURK PSIKIYATRI DERGISI, 2005, 16 (03) : 153 - 163
  • [6] Effect of reboxetine on major depressive disorder in breast cancer patients: An open-label study
    Grassi, L
    Biancosino, B
    Marmai, L
    Righi, R
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (04) : 515 - 520
  • [7] Reboxetine:: a double-blind comparison with fluoxetine in major depressive disorder
    Massana, J
    Möller, HJ
    Burrows, GD
    Montenegro, RM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (02) : 73 - 80
  • [8] Recognizing Inadequate Response in Patients With Major Depressive Disorder
    Jackson, W. Clay
    Papakostas, George I.
    Rafeyan, Roueen
    Trivedi, Madhukar H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (03)
  • [9] Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder
    Bozina, Nada
    Peles, Alma Mihaljevic
    Sagud, Marina
    Bilusic, Hrvoje
    Jakovljevic, Miro
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2008, 9 (03): : 190 - 197
  • [10] Therapeutic Response to Paroxetine in Major Depressive Disorder Predicted by DNA Methylation
    Takeuchi, Naohiro
    Nonen, Shinpei
    Kato, Masaki
    Wakeno, Masataka
    Takekita, Yoshiteru
    Kinoshita, Toshihiko
    Kugawa, Fumihiko
    NEUROPSYCHOBIOLOGY, 2017, 75 (02) : 81 - 88